- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2019-003563-22.
Displaying page 1 of 1.
EudraCT Number: 2019-003563-22 | Sponsor Protocol Number: CAT-1004-302 | Start Date*: 2020-04-23 | |||||||||||
Sponsor Name:Catabasis Pharmaceuticals Inc. | |||||||||||||
Full Title: An Open-Label Extension Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy | |||||||||||||
Medical condition: Duchenne Muscular Dystrophy | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (Prematurely Ended) IE (Prematurely Ended) DE (Prematurely Ended) SE (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.